DeborahEvaCitrinMD

Radiation Oncology • Bethesda, MD

Physician

Join to view full profile

Dr. Citrin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Citrin's full profile

Already have an account?

Office
10 Rockville Pike
# 10
Bethesda, MD 20892
Phone+1 301-496-5457

Education & Training

Duke University School of MedicineClass of 2000

Certifications & Licensure

MD State Medical License 2001 - 2026
VA State Medical License 2008 - 2026
American Board of Radiology Radiation Oncology

Clinical Trials

A Pilot Study of Markers of Tumor Burden and Radiation Toxicity in the Blood, Urine, and Stool of Patients Receiving Radiotherapy for Gastrointestinal Malignancies Start of enrollment: 2007 Feb 01
An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin Start of enrollment: 2009 Apr 23
Completed
A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum Start of enrollment: 2010 May 24
Terminated
Phase 1
Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer Start of enrollment: 2011 Mar 18
Terminated
Phase 1
ECI301 and Radiation for Advanced or Metastatic Cancer Start of enrollment: 2011 Sep 06
Terminated
Phase 1
Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers Start of enrollment: 2007 Feb 20
Terminated
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy Start of enrollment: 2013 Nov 13
Recruiting
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy Start of enrollment: 2018 Jul 05
Active, not recruiting
Phase 1
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy Start of enrollment: 2018 Jan 17
Active, not recruiting
Phase 1
A Study of Patients Receiving High-Dose Rate Brachytherapy Start of enrollment: 2009 Apr 14
Active, not recruiting
Phase 2
Roles: Contact, Principal Investigator
Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer Start of enrollment: 2021 Oct 01
Recruiting
Phase 1
Roles: Principal Investigator, Contact
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy Start of enrollment: 2022 Aug 31
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer Start of enrollment: 2024 Feb 15
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Radiotherapy toxicities: mechanisms, management, and future directions.
Ioannis I Verginadis, Deborah E Citrin, Bonnie Ky, Steven J Feigenberg, Alexandros G Georgakilas
Lancet. 2025-01-25
The Determinants of Toxicity in the Treatment of Prostate Cancer With a Focal, Intraprostatic "Microboost".
Krishnan R Patel, Alan Dal Pra, Erich P Huang, Sarah A Singh, Vivek Verma
International Journal of Radiation Oncology, Biology, Physics. 2025-01-23
Interleukin-13 Receptor Subunit Alpha 2 Induces Chemokine Expression and Macrophage Polarization to Promote Inflammation and Fibrosis.
Seokjoo Kwon, Eun Joo Chung, Santwana Kc, Ayla O White, Su I Chung
International Journal of Radiation Oncology, Biology, Physics. 2024-12-12

Press Mentions

GE HealthCare Showcases the Latest AI-Enhanced Radiation Therapy Solutions at ASTRO 2024September 26th, 2024
Alessa Therapeutics Announces IND Clearance for a Study in Collaboration with the National Cancer InstituteJune 7th, 2021
Can Low-Dose Radiotherapy Treat COVID-19-Related Pneumonia?November 3rd, 2020